Retatrutide Phase 3 Results: New Weight Loss Jab Outperforms Mounjaro in Landmark Trial
If you have been following the world of weight loss jabs, you will know that Mounjaro (tirzepatide) was considered a game-changer. It helped people lose around 20-22% of their body weight in clinical trials. Now a new contender has arrived — and the numbers are even bigger. On 21 May 2026, Eli Lilly published topline…
